###begin article-title 0
Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort study
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Intestinal metaplasia (IM) is an important precursor lesion in the development of gastric cancer (GC). The aim of this study was to investigate genetic factors previously linked to GC risk for their possible association with IM. A total of 18 polymorphisms in 14 candidate genes were evaluated in a Singapore-Chinese population at high risk of developing GC.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
Genotype frequencies were compared between individuals presenting with (n = 128) or without (n = 246) IM by both univariate and multivariate analysis.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 105 125 105 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 160 162 160 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 175 181 175 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 271 273 271 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 381 383 381 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 473 475 473 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 105 124 <span type="species:ncbi:210">Helicobacter pylori</span>
Carriers of the NQO1 609 T allele showed an association with IM in individuals who were seropositive for Helicobacter pylori (HP+; OR = 2.61, 95%CI: 1.18-5.80, P = .018). The IL-10 819 C allele was also associated with IM in HP+ individuals (OR = 2.32, 95%CI: 1.21-4.43, P = 0.011), while the PTPN11 A allele was associated with IM in HP- individuals (OR = 2.51, 95%CI: 1.16-5.40, P = 0.019), but showed an inverse association in HP+ subjects (OR = 0.46, 95%CI: 0.21-0.99, P = 0.048).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1</italic>
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11</italic>
Polymorphisms in NQO1, IL-10 and PTPN11, in combination with HP status, could be used to identify individuals who are more likely to develop IM and therefore GC.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 624 644 624 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 746 747 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 624 643 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 645 647 <span type="species:ncbi:210">HP</span>
###xml 910 912 <span type="species:ncbi:210">HP</span>
Gastric cancer (GC) is the second leading cause of cancer-related mortality worldwide, with more than 700,000 deaths annually[1]. The late presentation of this disease is the main reason for the high mortality and highlights the importance of early detection[2]. In Japan, mass screening programs began in the 1960's and led to a significant increase in the proportion of GC diagnosed at an early stage from 8% in 1960-1964 to 50% in 1975-1979. However, more cost-effective screening programs that target high risk groups are needed because of the limited resources available in many Asian countries. Positive assessment of Helicobacter pylori (HP) infection can help to identify high risk individuals since this is a proven risk factor for GC[3,4]. Various genetic factors have also been associated with an increased risk for the development of GC [5-8]. These polymorphisms could be used in conjunction with HP status and together with dietary and environmental factors to target screening programs towards individuals deemed to be at high risk.
###end p 11
###begin p 12
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 747 755 747 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#946;</italic>
###xml 757 762 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10</italic>
###xml 764 770 761 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11</italic>
###xml 773 775 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 776 778 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 800 808 797 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FR-&#945;</italic>
###xml 810 815 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR</italic>
###xml 817 819 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 820 822 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 838 841 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGF</italic>
###xml 843 847 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HER2</italic>
###xml 850 852 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 853 855 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 873 877 866 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STCH</italic>
###xml 879 881 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 899 903 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP2</italic>
###xml 905 907 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 935 939 928 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1</italic>
###xml 941 948 934 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SULT1A1</italic>
###xml 950 954 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP53</italic>
###xml 956 961 949 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADPRT</italic>
###xml 964 966 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 967 969 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
GC is thought to arise via a multi-step pathway that involves intestinal metaplasia (IM) as a precursor lesion[9]. It has been estimated that 0.25-1.1% of IM lesions will progress to GC annually, representing an 18-78-fold increased lifetime risk of developing this disease in comparison to the general population[10,11]. In the present study, we have investigated a panel of 18 polymorphisms in 14 candidate genes for their association with IM precursor lesions in a Singapore-Chinese population considered to be at increased risk of GC because of age greater than 50 years. These polymorphisms were chosen for study because previous research has shown them to be risk factors for GC. They included SNPs in genes involved in the immune response (IL-1beta, IL-10, PTPN11) [12-14], folate metabolism (FR-alpha, MTHFR)[15,16], cell growth (EGF, HER2) [17-19], cell survival (STCH)[20], cell invasion (MMP2)[21] and DNA damage or repair (NQO1, SULT1A1, TP53, ADPRT) [22-26].
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Subjects
###end title 14
###begin p 15
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Subjects were recruited from the Gastric Cancer Epidemiology and Molecular Genetics Program (GCEP). This project is a prospective cohort study aiming to enroll 4,000 Singapore-Chinese subjects aged more than 50 years from four major public hospitals in Singapore (National University Hospital, Tan Tock Seng Hospital, Singapore General Hospital, Changi General Hospital). It offers screening by endoscopy and systematic follow-up for a minimum of 5 years [27]. Chinese subjects older than 50 years of age who met the following criteria were eligible to enroll in the study: (i) symptoms of dyspepsia (ie. bloating, distension, nausea, stomach pain etc), (ii) family history of gastric cancer, or (iii) a medical condition that required them to undergo gastroscopy. They must also be able to attend all study visits assigned to them. Subjects who could not undergo gastroscopy, had a history of stomach cancer or surgery, had a disabling illness, or were unable to provide informed consent were ineligible for the study. Clinical information including demographics, medical history and family history were obtained. Informed consent was obtained from all subjects and the study was approved by the institutional review boards of all hospitals involved. Blood samples from 374 individual subjects collected between April 2004 and December 2006 were used for genotyping in the present study.
###end p 15
###begin p 16
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 395 404 <span type="species:ncbi:210">H. pylori</span>
###xml 548 550 <span type="species:ncbi:210">HP</span>
###xml 700 702 <span type="species:ncbi:210">HP</span>
Three biopsies from the antrum, body and cardia were collected for histopathological examination during each endoscopic surveillance episode. IM was diagnosed from mucosal biopsies in three locations (antrum, body and cardia) for each subject and by consensus amongst three pathologists according to the updated Sydney System for the classification and grading of gastritis [28]. In cases where H. pylori was identified in biopsies, eradication therapy was administered according to standard clinical guidelines. For 339/374 (91%) individuals, the HP status was determined using the Helicoblot2.1 serology test (Genelabs Diagnostics, Singapore). In individuals where this test was not performed, the HP status was determined from histological examination of biopsies from the antrum, body and cardia, as well as from past medical history. Blood samples (8 mls) were collected into Vacutainer CPT tubes (Becton Dickinson, Franklin Lakes, NJ) and the mononuclear cells isolated and stored at -80degreesC prior to DNA extraction using Tri-Reagent (MRC Inc, Cincinnati, OH).
###end p 16
###begin title 17
Helicoblot2.1 serology test
###end title 17
###begin p 18
###xml 173 182 <span type="species:ncbi:210">H. pylori</span>
###xml 212 221 <span type="species:ncbi:210">H. pylori</span>
###xml 373 382 <span type="species:ncbi:210">H. pylori</span>
###xml 469 473 <span type="species:ncbi:9925">goat</span>
###xml 479 484 <span type="species:ncbi:9606">human</span>
###xml 798 807 <span type="species:ncbi:210">H. pylori</span>
This serological assay uses a Western Blot nitrocellulose strip containing electrophoretically separated proteins from a bacterial lysate of an ulcer-causing type strain of H. pylori and a recombinant antigen of H. pylori (Genelabs Diagnostics, Singapore). When incubated with diluted serum/plasma, specific antibodies to the various antigens, if present, will bind to the H. pylori antigens on the strip. These bound antibodies appear as dark bands upon reaction with goat anti-human IgG conjugated with alkaline phosphatase and a 5-bromo-4-chloro-2-indolyl-phosphate/nitroblue tetrazolium substrate solution. In order to identify the various bands present, the strip is compared with reference strips of non-reactive (negative) and reactive (positive) controls run concurrently. Determination of H. pylori seropositivity was based on criteria recommended by the kit manufacturer. They consist of (1), 116 kD (CagA) positive band present with one or more of the following bands: 89 kD (VacA), 37 kD, 35 kD, 30 kD (UreA) and 19.5 kD together, or with the current infection marker, (2) the presence of any one band at 89 kD (VacA), 37 kD or 35 kD, with or without current infection marker, or (3) the presence of both 30 kD and 19.5 kD with or without current infection marker.
###end p 18
###begin title 19
Selection of gene polymorphism panel
###end title 19
###begin p 20
A systematic literature search in PubMed was carried out using the terms "gastric cancer" and "polymorphism". From a total of 78 candidate polymorphisms identified, 18 were found to be significantly associated with the risk of GC and were therefore included in the current investigation of IM.
###end p 20
###begin title 21
Genotyping
###end title 21
###begin p 22
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ILRN </italic>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
Table 1 shows the PCR primers, annealing temperatures and product sizes for 17 SNPs investigated in this study by pyroseqeuncing. The 86-bp variable number of tandem repeats (VNTR) polymorphism in ILRN was genotyped using PCR followed by size analysis using gel electrophoresis. The primers and PCR conditions were the same as previously reported[29]. Polymorphisms were recorded in their most commonly used notation for easy cross-referencing. For PCR, 50 ng DNA was amplified in a 25 mul reaction containing 1 x FastStart Reaction Buffer, 2 mM magnesium chloride, 10 muM deoxynucleotide mix, 500 nM each of the forward and reverse primers and 1 unit FastStart Taq Polymerase (Roche Diagnostics, Mannheim, Germany). PCR cycling comprised of 4 minutes at 95degreesC, followed by 35 cycles of 30 seconds at 95degreesC, 30 seconds at the appropriate annealing temperature and 30 seconds at 72degreesC, before conclusion with 7 minutes at 72degreesC.
###end p 22
###begin p 23
PCR primers and dispensation sequences for pyrosequencing of 17 SNPs evaluated for association with IM.
###end p 23
###begin p 24
###xml 558 559 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Pyrosequencing was performed by incubating the PCR products with 3 mul of streptavidin magnetic beads (Amersham Pharmacia Biotech, Uppsala, Sweden) and 1x binding buffer (10 mM Tris-HCl, 2 M NaCl, 1 mM EDTA, 0.1% Tween 20) and mixing for 10 minutes at 37degreesC. The product mix was then denatured by 5 seconds incubation in 0.2 M NaOH solution and washed in annealing buffer (20 mM Tris-acetate, 2 mM magnesium acetate) for 10 seconds. The single-stranded products were transferred to an annealing buffer containing 15 pmol of the sequencing primer (Table 1) and incubated for 2 minutes at 80degreesC in a Hybaid Maxi 14 hybridization oven (Thermo Electron, USA). Pyrosequencing was then performed on a PSQ96MA pyrosequencer instrument (Biotage AB, Uppsala, Sweden). Samples that failed to give a genotype result after the first analysis were repeated up to two times. The genotyping success rate varied from 85-99% for the 18 polymorphisms.
###end p 24
###begin title 25
Statistics
###end title 25
###begin p 26
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL10 </italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STCH</italic>
###xml 400 402 <span type="species:ncbi:210">HP</span>
###xml 408 410 <span type="species:ncbi:210">HP</span>
Univariate analyses were carried out by Pearson's chi-square or the Fisher's exact test to examine for associations between genotype distributions, IM status and clinical factors. As there were more than one polymorphism investigated in IL10 and STCH, the haplotypes were also considered in the analyses. Variables found significantly associated with IM in the univariate analyses for all cases, and HP+ and HP- subgroups were entered in respective multivariate logistic regression models. The analyses were based on the assumption of a dominant genetic model. All statistical analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, IL) software at the 5% significance level. The Woolf test was used to test for homogeneity of OR between two strata. As each polymorphism was tested for association with IM independently, it was not necessary to control for the family-wise error rate. Thus, no adjustment was made for multiple testing.
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 250 253 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">st </sup>
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 528 530 528 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 494 496 <span type="species:ncbi:210">HP</span>
The characteristics of 374 subjects evaluated in this study are shown in Table 2. A total of 128 were diagnosed with IM and 246 without IM. No significant differences between IM+ and IM- groups were apparent for sex, family history of GC (including 1st degree and 2nd degree relatives), alcohol consumption (at least one unit of wine, beer or liquor per week) or smoking status (at least one cigarette per day for a minimum of one year). IM+ subjects showed a significantly higher incidence of HP infection and were also older (P < 0.05).
###end p 28
###begin p 29
Characteristics of study subjects in relation to the presence of IM.
###end p 29
###begin p 30
###xml 2 4 2 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
* P < 0.05
###end p 30
###begin p 31
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL10 </italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP53 </italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 402 404 402 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 443 450 443 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 536 538 536 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 639 645 639 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 688 690 688 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 748 750 748 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 763 770 763 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 809 811 809 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 839 844 839 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL10 </italic>
###xml 848 853 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STCH </italic>
###xml 417 419 <span type="species:ncbi:210">HP</span>
###xml 571 573 <span type="species:ncbi:210">HP</span>
###xml 914 916 <span type="species:ncbi:210">HP</span>
###xml 930 932 <span type="species:ncbi:210">HP</span>
Genotype frequencies for the 18 polymorphisms investigated for association with IM are presented in Table 3. All polymorphisms were in Hardy-Weinberg equilibrium (P > 0.05), with the exception of IL10 -819T/C, NQO1 609C/T and TP53 Arg72Pro. By univariate analysis, the NQO1 609 T allele was the only variant in the overall cohort that was significantly associated with IM (OR = 1.82, 95%CI: 1.05-3.15, P = 0.032). In HP- individuals, only the PTPN11 rs2301756 A allele was significantly associated with IM (OR = 2.51, 95%CI: 1.16-5.40, P = 0.019). Three polymorphisms in HP+ individuals were associated with IM in univariate analysis: the IL-10 819 C allele (OR = 2.32, 95%CI: 1.21-4.43, P = 0.011), NQO1 609 T allele (OR = 2.61, 95%CI: 1.18-5.80, P = 0.018) and PTPN11 A allele (OR = 0.46, 95%CI: 0.21-0.99, P = 0.048). The haplotypes in IL10 and STCH were not significantly associated with IM in overall cohort, HP-, as well as HP+ groups.
###end p 31
###begin p 32
###xml 57 59 <span type="species:ncbi:210">HP</span>
Distribution of genotype frequencies according to IM and HP infection status
###end p 32
###begin p 33
* Bold type denotes significant difference in genotype frequencies
###end p 33
###begin p 34
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 197 204 197 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 333 339 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 356 363 356 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 512 519 512 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 529 531 529 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 777 779 777 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 792 798 792 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 842 844 842 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 50 52 <span type="species:ncbi:210">HP</span>
###xml 176 178 <span type="species:ncbi:210">HP</span>
###xml 265 267 <span type="species:ncbi:210">HP</span>
###xml 442 444 <span type="species:ncbi:210">HP</span>
###xml 568 570 <span type="species:ncbi:210">HP</span>
###xml 613 615 <span type="species:ncbi:210">HP</span>
###xml 674 676 <span type="species:ncbi:210">HP</span>
###xml 694 696 <span type="species:ncbi:210">HP</span>
###xml 703 705 <span type="species:ncbi:210">HP</span>
###xml 714 716 <span type="species:ncbi:210">HP</span>
In multivariate analysis that included all cases, HP status and age were significantly associated with IM, while the NQO1 T allele showing borderline association (Table 4). In HP- individuals, the PTPN11 A allele was the only factor associated with IM. However, in HP+ individuals the factors of older age and the NQO1 609 T allele, IL-10 819 C allele and PTPN11 A allele were all significantly associated with IM. These results suggest that HP status is an effect modifier of the association between IM and the PTPN11 A allele (P = 0.002). As it is possible that IM+/HP- cases in this study had prior unrecorded HP infection[30], subgroup analysis on cases with a "revised HP+" status (either HP+/IM-, HP+/IM+ or HP-/IM+) was also performed. Age (OR = 2.10, 95%CI: 1.24-3.56, P = 0.006) and IL-10 -819 C allele (OR = 1.82, 95%CI: 1.07-3.08, P = 0.027) were the only significant variables in this subgroup.
###end p 34
###begin p 35
Multivariate logistic regression analysis for associations with IM.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 498 500 <span type="species:ncbi:210">HP</span>
In this study, 18 polymorphisms that were previously linked to GC were investigated for possible associations with IM in a Singapore-Chinese population. The assumption was made that IM represents a precursor lesion for the development of GC and hence should have similar genetic risk factors. The cohort evaluated here was considered to be at elevated risk for GC because of the selection of individuals aged >50 years[27]. As expected, older individuals and those demonstrating seropositivity for HP showed a doubling in the frequency of IM (Table 4).
###end p 37
###begin p 38
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 163 169 163 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 258 265 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 518 523 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 609 611 609 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 142 144 <span type="species:ncbi:210">HP</span>
###xml 228 230 <span type="species:ncbi:210">HP</span>
###xml 347 349 <span type="species:ncbi:210">HP</span>
###xml 392 394 <span type="species:ncbi:210">HP</span>
Following univariate analysis, 3 genotypes were found to be associated with IM. The NQO1 609 T allele was associated with IM, particularly in HP+ individuals. The IL-10 -819 C allele was also significantly associated with IM in HP+ cases. Interestingly, the PTPN11 A allele in intron 3 (rs2301756) was associated with increased incidence of IM in HP- individuals but a decreased incidence in HP+ cases. In multivariate analysis, all 3 polymorphisms remained significantly associated with IM, with the exception of the NQO1 609 T allele which was associated with borderline significance in the overall cohort (P = 0.056).
###end p 38
###begin p 39
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 778 783 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 900 905 900 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 64 71 <span type="species:ncbi:50278|species:ncbi:153742">quinine</span>
###xml 687 695 <span type="species:ncbi:9606">patients</span>
Previous data lends support to our observations. NQO1 (NAD(P)H: quinine oxidoreductase 1) codes for a cytosolic enzyme that protects cells from oxidative damage by preventing the generation of semiquinone free radicals and reactive oxygen species[31]. The C to T substitution at nucleotide 609 in exon 6 results in a change of amino acid from Pro to Ser at codon 187[32]. Whereas the CC homozygous wildtype genotype (Pro/Pro) has full enzymatic activity, the TT genotype (Ser/Ser) completely lacks activity. The NQO1 609 TT genotype has been associated with an increased risk for various tumour types including gastrointestinal and urological cancers [33-36]. An increased risk of GC in patients with a family history of upper gastrointestinal cancers was also reported for the NQO1 609 TT genotype in a study on Chinese subjects[22]. Our observation of increased prevalence of IM in carriers of the NQO1 609 T allele concurs with earlier reports on its association with various cancers and can be explained by a decreased activity for the detoxification of environmental and dietary carcinogens.
###end p 39
###begin p 40
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 77 79 <span type="species:ncbi:210">HP</span>
###xml 197 199 <span type="species:ncbi:210">HP</span>
###xml 284 286 <span type="species:ncbi:210">HP</span>
The NQO1 C609T polymorphism was previously associated with seropositivity to HP in a Japanese study[37], thus raising the possibility that it is an indirect risk factor for IM via association with HP infection. However, we found no association between the NQO1 C609T polymorphism and HP infection in the present cohort (results not shown).
###end p 40
###begin p 41
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NQO1 </italic>
###xml 228 234 228 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 303 309 303 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 538 544 538 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 144 146 <span type="species:ncbi:210">HP</span>
###xml 258 260 <span type="species:ncbi:210">HP</span>
Carriers of the IL-10 -819 C allele express higher mucosal levels of IL-10 (interleukin 10) mRNA and experience colonization with more virulent HP strains[38]. Similar to NQO1 C609T, no association was observed here between the IL-10 T-819C polymorphism and HP infection. The current result showing the IL-10 -819 C allele is associated with IM is at odds with an Italian study that reported the TT genotype was associated with increased risk of IM[29] However, two studies in Chinese and German populations found no associations between IL-10 T-819C and IM[38,39].
###end p 41
###begin p 42
###xml 34 43 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#946; </italic>
###xml 47 50 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF</italic>
###xml 168 170 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 171 173 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 174 176 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 177 179 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 186 195 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#946; </italic>
###xml 206 212 196 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 371 372 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 405 414 395 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#946; </italic>
###xml 461 463 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 464 466 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 493 495 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 541 547 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 </italic>
###xml 575 577 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 578 580 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 611 613 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 614 616 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 617 619 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 125 127 <span type="species:ncbi:210">HP</span>
###xml 334 336 <span type="species:ncbi:210">HP</span>
Other common polymorphisms in the IL-1beta and TNF-alpha cytokine genes have been proposed to influence the host response to HP and therefore the risk of developing GC[13,29,38-42]. The IL-1beta C-511T and IL-10 A-1082G polymorphisms were investigated in this cohort, but no significant associations were found with seropositivity to HP or with the presence of IM (Table 3). Previous studies reported the IL-1beta -511 T allele increased the risk of IM in some[38,39], but not all populations[12]. One study found an association between the IL-10 A-1082G polymorphism and IM[12,43], but 3 other studies did not[12,29,39].
###end p 42
###begin p 43
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 349 356 349 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 849 856 849 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 235 237 <span type="species:ncbi:210">HP</span>
###xml 448 450 <span type="species:ncbi:210">HP</span>
###xml 615 617 <span type="species:ncbi:210">HP</span>
###xml 1074 1076 <span type="species:ncbi:210">HP</span>
PTPN11 (protein tyrosine phosphatase, non-receptor type 11) encodes for SHP-2, a protein tyrosine phosphatase thought to play a key role in intracellular signaling elicited by growth factors and cytokines[44]. Interactions between the HP cagA protein and SHP-2 in gastric epithelial cells are believed to contribute to the development of GC[45] The PTPN11 AA genotype was associated with reduced risk of gastric atrophy in a Japanese population of HP seropositive individuals [14,30]. In those studies, the assessment of gastric atrophy was done with serology test (pepsinogen levels). The present results on IM in HP seropositive Singapore-Chinese support these earlier observations, although the number of AA genotype individuals (n = 6) did not allow separate evaluation of this group. The diagnosis of IM was based on histology examination. The PTPN11 intron 3 G/A SNP may be in linkage disequilibrium with a coding marker that influences the interaction of SHP-2 with cagA and subsequent downstream signaling. However, its association with increased frequency of IM in HP negative individuals suggests it may play a role independently of this factor.
###end p 43
###begin title 44
Conclusion
###end title 44
###begin p 45
###xml 163 165 <span type="species:ncbi:210">HP</span>
In summary, we found 3 polymorphisms associated with IM in a Singapore-Chinese population that was at high risk for GC because of older age and seropositivity for HP. The value of these SNPs in facilitating more cost-effective surveillance programs awaits further validation in large, independent cohorts.
###end p 45
###begin title 46
Competing interests
###end title 46
###begin p 47
The authors declare that they have no competing interests.
###end p 47
###begin title 48
Authors' contributions
###end title 48
###begin p 49
FZ participated in the design of the study and its coordination, performed the statistical analysis and drafted the manuscript. ML performed the literature review/statistical analysis and drafted the manuscript. JH, KWL, MST and KGY provided clinical and biological insights for the study. SL and KXK carried out the genotyping of the samples. BI drafted the manuscript. RS participated in its design and coordination, supervised the study and drafted the manuscript. All authors read and approved the final manuscript.
###end p 49
###begin title 50
Pre-publication history
###end title 50
###begin p 51
The pre-publication history for this paper can be accessed here:
###end p 51
###begin p 52

###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
This work was funded in part by the National Medical Research Council of Singapore (NMRC/TCR/001-NUS/2007), Biomedical Research Council of Singapore (BMRC 04/1/21/19/312) and the Singapore Cancer Syndicate (SCS#BU51, SCS#GN015). The authors would like to thank contributors from the Singapore Gastric Cancer Consortium that include Khek Yu HO, Yoshiaki ITO, Christopher JL KHOR, Andrea RAJNAKOVA, Kwong Ming FOCK, Choon Jin OOI, Chung King CHIA, Wee Chian LIM, Wai Keong WONG, Andrew WONG, Ming TEH, Nilesh SHAH, Robert HEWITT, Bow HO, Kee Seng CHIA, Yoon Pin LIM, Jimmy JB SO, Lynette PHAY.
###end p 54
###begin article-title 55
Global cancer statistics
###end article-title 55
###begin article-title 56
Gastric cancer: a 25-year review
###end article-title 56
###begin article-title 57
###xml 86 105 <span type="species:ncbi:210">Helicobacter pylori</span>
Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study
###end article-title 57
###begin article-title 58
###xml 46 65 <span type="species:ncbi:210">Helicobacter pylori</span>
Development of gastric cancer associated with Helicobacter pylori infection
###end article-title 58
###begin article-title 59
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway
###end article-title 59
###begin article-title 60
Genetic pathways of two types of gastric cancer
###end article-title 60
###begin article-title 61
Interleukin-1B polymorphisms and gastric cancer risk--a meta-analysis
###end article-title 61
###begin article-title 62
###xml 47 66 <span type="species:ncbi:210">Helicobacter pylori</span>
Genetic factors involved in the development of Helicobacter pylori-related gastric cancer
###end article-title 62
###begin article-title 63
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention
###end article-title 63
###begin article-title 64
The long term results of endoscopic surveillance of premalignant gastric lesions
###end article-title 64
###begin article-title 65
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands
###end article-title 65
###begin article-title 66
###xml 25 44 <span type="species:ncbi:210">Helicobacter pylori</span>
Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica
###end article-title 66
###begin article-title 67
Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese
###end article-title 67
###begin article-title 68
###xml 85 104 <span type="species:ncbi:210">Helicobacter pylori</span>
Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese
###end article-title 68
###begin article-title 69
Polymorphisms and mutations of the folate receptor-alpha gene and risk of gastric cancer in a Chinese population
###end article-title 69
###begin article-title 70
Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population
###end article-title 70
###begin article-title 71
A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer
###end article-title 71
###begin article-title 72
Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population
###end article-title 72
###begin article-title 73
A single nucleotide polymorphism in the transmembrane domain coding region of HER-2 is associated with development and malignant phenotype of gastric cancer
###end article-title 73
###begin article-title 74
A genetic variant in the gene encoding the stress70 protein chaperone family member STCH is associated with gastric cancer in the Japanese population
###end article-title 74
###begin article-title 75
A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma
###end article-title 75
###begin article-title 76
Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population
###end article-title 76
###begin article-title 77
###xml 73 80 <span type="species:ncbi:4097">tobacco</span>
Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population
###end article-title 77
###begin article-title 78
Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan
###end article-title 78
###begin article-title 79
Adenosine diphosphate ribosyl transferase and x-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer
###end article-title 79
###begin article-title 80
[Correlation of genetic polymorphisms in DNA repair genes ADPRT and XRCC1 to risk of gastric cancer]
###end article-title 80
###begin article-title 81
Screening for gastric cancer in Asia: current evidence and practice
###end article-title 81
###begin article-title 82
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994
###end article-title 82
###begin article-title 83
###xml 60 79 <span type="species:ncbi:210">Helicobacter pylori</span>
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome
###end article-title 83
###begin article-title 84
Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese
###end article-title 84
###begin article-title 85
###xml 64 69 <span type="species:ncbi:9606">human</span>
Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells
###end article-title 85
###begin article-title 86
Presence of a heterozygous substitution and its relationship to DT-diaphorase activity
###end article-title 86
###begin article-title 87
Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract
###end article-title 87
###begin article-title 88
NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China
###end article-title 88
###begin article-title 89
NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors
###end article-title 89
###begin article-title 90
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies
###end article-title 90
###begin article-title 91
###xml 20 39 <span type="species:ncbi:210">Helicobacter pylori</span>
Association between Helicobacter pylori seropositivity and NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism observed in outpatients and health checkup examinees
###end article-title 91
###begin article-title 92
###xml 127 146 <span type="species:ncbi:210">Helicobacter pylori</span>
Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection
###end article-title 92
###begin article-title 93
###xml 0 9 <span type="species:ncbi:210">H. pylori</span>
H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population
###end article-title 93
###begin article-title 94
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
###end article-title 94
###begin article-title 95
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma
###end article-title 95
###begin article-title 96
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
###end article-title 96
###begin article-title 97
Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela
###end article-title 97
###begin article-title 98
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
###end article-title 98
###begin article-title 99
###xml 57 76 <span type="species:ncbi:210">Helicobacter pylori</span>
SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein
###end article-title 99

